Pharma Mar SA
MAD:PHM

Watchlist Manager
Pharma Mar SA Logo
Pharma Mar SA
MAD:PHM
Watchlist
Price: 97.65 EUR 1.82% Market Closed
Market Cap: 1.8B EUR
Have any thoughts about
Pharma Mar SA?
Write Note

Wall Street
Price Targets

PHM Price Targets Summary
Pharma Mar SA

Wall Street analysts forecast PHM stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHM is 80.38 EUR with a low forecast of 29.9 EUR and a high forecast of 105 EUR.

Lowest
Price Target
29.9 EUR
69% Downside
Average
Price Target
80.38 EUR
18% Downside
Highest
Price Target
105 EUR
8% Upside
Pharma Mar SA Competitors:
Price Targets
688428
InnoCare Pharma Ltd
32% Upside
UTHR
United Therapeutics Corp
10% Upside
OXB
Oxford BioMedica PLC
41% Upside
ANIK
Anika Therapeutics Inc
51% Upside
ORGO
Organogenesis Holdings Inc
38% Upside
PRME
Prime Medicine Inc
407% Upside
PAR
Paradigm Biopharmaceuticals Ltd
58% Upside
GNS
Genus PLC
30% Upside

Revenue
Forecast

Revenue Estimate
Pharma Mar SA

For the last 8 years the compound annual growth rate for Pharma Mar SA's revenue is -3%. The projected CAGR for the next 4 years is 25%.

-3%
Past Growth
25%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Pharma Mar SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Pharma Mar SA

For the last 8 years the compound annual growth rate for Pharma Mar SA's net income is -20%. The projected CAGR for the next 4 years is 267%.

-20%
Past Growth
267%
Estimated Growth
Estimates Accuracy
-6%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHM's stock price target?
Price Target
80.38 EUR

According to Wall Street analysts, the average 1-year price target for PHM is 80.38 EUR with a low forecast of 29.9 EUR and a high forecast of 105 EUR.

What is Pharma Mar SA's Revenue forecast?
Projected CAGR
25%

For the last 8 years the compound annual growth rate for Pharma Mar SA's revenue is -3%. The projected CAGR for the next 4 years is 25%.

What is Pharma Mar SA's Net Income forecast?
Projected CAGR
267%

For the last 8 years the compound annual growth rate for Pharma Mar SA's net income is -20%. The projected CAGR for the next 4 years is 267%.

Back to Top